Onyx Biotec Limited IPO
NSE SMEListed On: Nov 22, 2024 at ₹ 54.05
₹ 122000 /2000 Shares
Check Allotment13 Nov, 2024
Open Date18 Nov, 2024
Close Date19 Nov, 2024
Allotment Date22 Nov, 2024
Listing DateIssue Price
₹58-61 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
Mas Services LimitedList Price
54.05Listing Date
2024-11-22Market Lot
2000 Shares (₹122,000/-)Lead Manager
Horizon Management Private LimitedIssue Size
4,810,000 shares(aggregating up to ₹29.34 Cr)Retail Portion
35%Subscription
198.68 timesIPO Docs
DRHPOnyx Biotec IPO Subscription Details
As on | QIB / NII | Retail | Total |
---|---|---|---|
Shares Offered / Reserved | 912,000 / 688,000 | 1,600,000 | 3,200,000 |
Day 1 - 13-11-24 06:00 PM | 0.00 / 1.70 x | 5.57 x | 3.15 x |
Day 2 - 14-11-24 06:00 PM | 0.00 / 8.15 x | 16.40 x | 9.95 x |
Day 3 - 18-11-24 06:00 PM | 32.49 / 603.44 x | 119.36 x | 198.68 x |
Onyx Biotec Valuations
EPS Pre IPO
₹2.28/-EPS Post IPO
₹4.33/-P/E Pre IPO
26.81P/E Post IPO
14.1RoNW
%Onyx Biotec Company Financials All values are in ₹ Lakh
31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
---|---|---|---|
Assets | 7,413.58 | 5,872.36 | 3,683.84 |
Revenue | 5,387.43 | 3,961.65 | 4,498.09 |
Profit After Tax | 303.16 | 184.46 | 335.29 |
About The Company
Onyx Biotec Limited is a pharmaceutical company providing sterile water for injections. The company currently manufactures Sterile Water for Injections and serves as a pharmaceutical contract manufacturer, offering a comprehensive range of Dry Powder Injections and Dry Syrups for both the Indian and overseas markets.
The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has a daily production capacity of 638,889 units of Sterile Water for Injections, while Unit II produces 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift.
The company clientele includes Hetero Healthcare Limited, Mankind Pharma Limited, Sun Pharmaceutical Industries Limited, Aristo Pharmaceuticals Private Limited, Macleods Pharmaceuticals Limited, Mapra Laboratories Private Limited, Axa Parenterals Limited, FDC Limited, Zuventus Healthcare Limited, Akums Drugs and Pharmaceuticals Limited, Reliance Life Sciences Limited, among others.
Onyx Biotec - Promoter(s)
Pre Issue Share Holding: %
Post Issue Share Holding: %
- Sanjay Jain
- Naresh Kumar
- Fateh Pal Singh
Onyx Biotec IPO - Issue Objectives
- Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections
- Prepayment or repayment of all or a portion of certain loans availed by the Company
- General Corporate Purposes.
Onyx Biotec IPO - FAQs
Ans. Onyx Biotec Limited IPO is a SME IPO. The issue is priced at ₹58-61 per equity share. The minimum order quantity is 2000 Shares. The IPO opens on Nov 13, 2024, and closes on Nov 18, 2024. Mas Services Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Onyx Biotec Limited IPO opens on Nov 13, 2024 and closes on Nov 18, 2024.
Ans. The size of Onyx Biotec Limited IPO is 4,810,000 shares(aggregating up to ₹29.34 Cr).
Ans. The IPO price band is set between ₹58-61 per equity share.
Ans. To apply for Onyx Biotec Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Onyx Biotec Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Onyx Biotec Limited IPO is Nov 19, 2024.
Ans. The Onyx Biotec Limited IPO will be listed on Nov 22, 2024.
Ans. Follow the steps to check the allotment status for Onyx Biotec Limited IPO here.